well I've suspected. I can't keep them all straight: apokerace, macugen, sidelurker, bergy, etc. I wish message boards would limit registrations to 1 per IP address, and also not allow anonymous IP so you can't hide behind an anonymizer. Not sure how'd they deal with cell phones, but I'm sure there's a way.
dang I like your tough talkin', sidelurker. Makes me want to strap my six-shooters on, walk down main street, and go shoot up some butte!
Genfit's results are very mixed, but the trial failed without massaging the data. I'm out. I took a hit, although I got out by getting the news via Twitter before US investors, so I only took half of the drop.
I second the congrats on CNAT - I had it and let it go. May buy it back. I still have Genfit. That's a binary event coming up any day.
fininsun, mrk's drugs will be DOA. The market (i.e. the payers) wants something better if it's going to replace Harvoni. They want 6 and 8 week therapies, or even 4 week. One or possibly two combo pills. They want Achillion.
I'm with you Charles - this took me by surprise. However, I doubled my position. #$%$ far as the biotech sector goes, I'm not sure if we are in the first third of a 20%+ correction, or just another hiccup. I suspect the latter.
no particular reason other than its a conference and it's BLUE out there talking. Last public comment on SCD was Dec 9 that the SCD patient achieved neutrophil engraftment. We are now another 3-4 months out and so I'm thinking they may make a comment about how the patient is doing, without having any conclusions yet.
thanks Magnam! I have to admit, I haven't done full DD on Esperion, other than looking at the data from last trial. I bought today purely because of the $15 drop to $87. It might drop to $80-84, in which case I may buy more.
last four trading days are higher than average volume. Today is 233% of average volume. We may have a bit more to go but tomorrow it could snap back just as easily...
big blood bath. Ironically, not so much in ACHN. I picked up some ESPR shares when they retraced 50% to $87. Now that all the green I have on the board today!
"denotes your Lack of Integrity or knowledge on this Field of Medicine."
Say what mac? pokey has a lack of integrity because he stated a legitimate fact about business executives in developing companies? Seriously? And he has lack of knowledge on [sic] this "Field of Medicine"? What field would that be mac, virology? You mean the one about which you have expressed endless scientific knowledge? Damn you can be annoying. #$%$!
Hi- did you buy? If it does another nosedive premarket I would get in then. It should build until June. One thing that I don't think was talked about much on this board was how advanced the patients were. This was stage 3-4 RCC. A few months of life left to a year or so. I still am at a loss as to why drugs are often tested first on these extremely hard to treat patients. For compassionate use, yes, but not for rigorous efficacy testing!
I took care of that problem Clutch! When GILD announced their "safety warning" I bought it a few bucks cheaper. Now I own both again - ACHN and GILD.
Charles, I don't know, but what I do know is that Pfizer is holding its license to ISONEP until after the trial results are out.